Literature DB >> 27432655

Involvement of endoplasmic reticulum stress and p53 in lncRNA MEG3-induced human hepatoma HepG2 cell apoptosis.

Rui-Pei Chen1, Zhen-Lun Huang1, Li-Xuan Liu1, Meng-Qi Xiang1, Guo-Ping Li1, Jia-Lin Feng2, Bin Liu3, Ling-Fei Wu1.   

Abstract

Long non-coding RNAs (lncRNAs) play important roles in diverse biological processes. Although downregulation of lncRNA maternally expressed gene 3 (MEG3) has been identified in several types of cancers, little is known concerning its biological role and regulatory mechanism in hepatoma. Our previous studies demonstrated that MEG3 induces apoptosis in a p53-dependent manner. The aim of the present study was to determine whether endoplasmic reticulum (ER) stress is involved in MEG3‑induced apoptosis. Recombinant lentiviral vectors containing MEG3 (Lv‑MEG3) were constructed and transfected into HepG2 cells. A 3‑(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, RT‑PCR, flow cytometry, western blot analysis, immunofluorescence and immunohistochemistry were applied. Transfected HepG2 cells were also transplanted into nude mice, and the tumor growth curves were determined. The results showed that the recombinant lentivirus of MEG3 was transfected successfully into the HepG2 cells and the expression level of MEG3 was significantly increased. Ectopic expression of MEG3 inhibited HepG2 cell proliferation in vitro and in vivo, and also induced apoptosis. Ectopic expression of MEG3 increased ER stress‑related proteins 78‑kDa glucose‑regulated protein (GRP78), inositol‑requiring enzyme 1 (IRE1), RNA‑dependent protein kinase‑like ER kinase (PERK), activating transcription factor 6 (ATF6), C/EBP homologous protein (CHOP), caspase‑3, as well as p53 and NF‑κB expression accompanied by NF‑κB translocation from the cytoplasm to the nucleus. Furthermore, inhibition of NF‑κB with Bay11‑7082 decreased p53 expression in the MEG3‑transfected cells. These results indicate that MEG3 inhibits cell proliferation and induces apoptosis, partially via the activation of the ER stress and p53 pathway, in which NF‑κB signaling is required for p53 activation in ER stress.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27432655     DOI: 10.3892/or.2016.4919

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

1.  The p53-inducible long noncoding RNA TRINGS protects cancer cells from necrosis under glucose starvation.

Authors:  Muhammad Riaz Khan; Shaoxun Xiang; Zhiyin Song; Mian Wu
Journal:  EMBO J       Date:  2017-10-18       Impact factor: 11.598

Review 2.  Stressing the Regulatory Role of Long Non-Coding RNA in the Cellular Stress Response during Cancer Progression and Therapy.

Authors:  Yi-Zhen Wu; Yong-Han Su; Ching-Ying Kuo
Journal:  Biomedicines       Date:  2022-05-23

3.  Identification of cancer risk lncRNAs and cancer risk pathways regulated by cancer risk lncRNAs based on genome sequencing data in human cancers.

Authors:  Yiran Li; Wan Li; Binhua Liang; Liansheng Li; Li Wang; Hao Huang; Shanshan Guo; Yahui Wang; Yuehan He; Lina Chen; Weiming He
Journal:  Sci Rep       Date:  2016-12-19       Impact factor: 4.379

4.  TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.

Authors:  Yucheng Zhong; Zhicong Chen; Shuyuan Guo; Xinhui Liao; Haibiao Xie; Yien Zheng; Bin Cai; Peixian Huang; Yuhan Liu; Qun Zhou; Yuchen Liu; Weiren Huang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

Review 5.  Long noncoding RNAs in head and neck cancer.

Authors:  Xiuhua Li; Yongbing Cao; Xiaojian Gong; Hongjiao Li
Journal:  Oncotarget       Date:  2017-02-07

Review 6.  A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases.

Authors:  Sanchari Roy; Christian Trautwein; Tom Luedde; Christoph Roderburg
Journal:  Front Pharmacol       Date:  2018-08-15       Impact factor: 5.810

Review 7.  The emergence of long non-coding RNAs in hepatocellular carcinoma: an update.

Authors:  Li Peng; Xiao-Qing Yuan; Chao-Yang Zhang; Jiang-Yun Peng; Ya-Qin Zhang; Xi Pan; Guan-Cheng Li
Journal:  J Cancer       Date:  2018-06-22       Impact factor: 4.207

8.  LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability.

Authors:  Haojun Wu; Yanxia He; Hang Chen; Yanzhi Liu; Bo Wei; Guanghua Chen; Han Lin; Hao Lin
Journal:  FEBS Open Bio       Date:  2019-03-20       Impact factor: 2.693

9.  Regulatory Network of Two Tumor-Suppressive Noncoding RNAs Interferes with the Growth and Metastasis of Renal Cell Carcinoma.

Authors:  Hui Zhou; Kun Tang; Haoran Liu; Jin Zeng; Heng Li; Libin Yan; Junhui Hu; Wei Guan; Ke Chen; Hua Xu; Zhangqun Ye
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-13       Impact factor: 8.886

Review 10.  Current research on head and neck cancer-associated long noncoding RNAs.

Authors:  Wei Song; Yimin Sun; Jie Lin; Xiaoqin Bi
Journal:  Oncotarget       Date:  2017-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.